• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

WKYMVM Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758376

MBS5758376 is an inhibitor targeting WKYMVM. WKYMVM is a N-formyl peptide receptor (FPR1) agonist. More details

Please Inquire
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
WKYMVM, Inhibitor
Full Product Name
WKYMVM
Product Gene Name
WKYMVM, inhibitor
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
856.11
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C41H61N9O7S2
SMILES
CSCC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](CCSC)C(N)=O)C(C)C
CAS Number
187986-17-0
Target & IC50
FPR1
Cell Research
Ligand-mediated internalization of FPRL1 and FPRL2 was followed by an indirect immunofluorescence microscopy staining technique. Cells were seeded on polyornithine-coated coverslips 48 h prior to the experiments. To stop protein synthesis, cells were incubated in RPMI 1640 medium containing 1% BSA and 100ug/ml cycloheximide for 3 hours and maintained in the same medium throughout the experiment. To study receptor internalization, RINm5F-FPRL1 cells and RINm5F-FPRL2 cells were treated with either WKYMVM or WKYMVm at 37 degree C for various time periods ranging from 0 to 30 minutes. Cells were finally fixed and permeabilized with acetone at -20 degree C for 30 s[1].
In Vitro
Neutrophils are activated by WKYMVM through FPRL1 and that FPRL2 is a chemotactic receptor transducing signals in myeloid cells[1].

Structure of WKYMVM, inhibitor

WKYMVM Inhibitor – Cat# MBS5758376

Product References and Citations for WKYMVM, inhibitor

Christophe T, Karlsson A, Dugave C, et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2[J]. Journal of Biological Chemistry, 2001, 276(24):21585-21593.
Christophe T, Karlsson A, Dugave C, et al. The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2[J]. Journal of Biological Chemistry, 2001, 276(24):21585-21593.
Kim H, Noh E K, Lee E J, et al. Enhanced bactericidal function by WKYMVm in patients with acute leukemia[J]. Leukemia Research, 2008, 32(5):717-725.
Kim H, Noh E K, Lee E J, et al. Enhanced bactericidal function by WKYMVm in patients with acute leukemia[J]. Leukemia Research, 2008, 32(5):717-725.

Other Notes

Small volumes of WKYMVM, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000